Altered cortical maturation in adolescent cannabis users with and without schizophrenia
Introduction
Adolescent brain development is characterized by ongoing molding of cortical gray matter (GM) (Sowell et al., 2001). During typical development, cortical maturation occurs in a back-to-front direction with the heteromodal association cortex (HASC) maturing last, during late adolescence and into early adulthood (Gogtay et al., 2004). The HASC comprises the prefrontal, superior temporal, and inferior parietal cortices and supports the highest integrative functions of the brain, including attention, language, working memory, and executive function (Ross and Pearlson, 1996). Within the HASC, the protracted maturation of the superior frontal cortex during adolescence is thought to subserve the development of executive functions (Luciana et al., 2009), including working memory and planning, that are important for the development of self-organized behavior and emotional regulation.
Cannabis is one of the most commonly used illicit substances among adolescents and young adults (SAMHSA, 2014). There are increasing data suggesting that the effects of delta-9-tetrahydrocannabinol (THC) may be more deleterious in adolescents, whose cognitive development and brain maturation are still ongoing, than in adults (Lisdahl et al., 2013). Recently, a primate study found that exposure to THC for six months during adolescence selectively impaired development of a spatial working memory task that preferentially activates the still-developing superior frontal cortex (Verrico et al., 2014). The primary target of exogenous cannabinoids in the brain is the cannabinoid-1 (CB-1) receptor. CB-1 receptors are located throughout the brain including the HASC and are part of the endocannibinoid system, which regulates synaptic plasticity and other fundamental neuromaturational processes (Harkany et al., 2008). To date, very little is known about the relationship between regular cannabis use during adolescence and cortical GM development in late-developing brain regions such as the HASC. Data from cross-sectional studies suggest that regular cannabis use during adolescence may disrupt GM pruning processes in both typical (Cousijn et al., 2012, Squeglia et al., 2009) and atypical development (Jarvis et al., 2008). Specifically, a study of adolescent cannabis users (mean age = 17.8) found reduced cortical thickness in prefrontal and insular regions, and increased cortical thickness in temporal and parietal regions, compared to healthy controls (HC) (Lopez-Larson et al., 2011). In contrast, a study in young adult cannabis users (mean age = 25.7) found no differences in cortical thickness between cannabis users and HC (Mata et al., 2010). However, in the latter study, HC participants were noted to have decreasing cortical thickness with age, while this pattern was not observed in cannabis users (Mata et al., 2010). These data support a working hypothesis that recurrent exposure to cannabis during adolescence could alter the maturation of cortical GM (Bossong and Niesink, 2010) within the HASC leading to an ostensible normalization of cortical structural abnormalities in adulthood.
Cannabis use disorder (CUD) is frequently diagnosed in patients with schizophrenia (SZ) (Koskinen et al., 2010). Schizophrenia is characterized by cortical abnormalities within the HASC (Buchanan et al., 2004), and the presence of CUD may be a moderating factor contributing to gray matter alterations in SZ. There is increasing evidence suggesting that patients with SZ and comorbid CUD may represent a clinically distinct subgroup of SZ patients with better premorbid adjustment (Dixon et al., 1991), superior cognitive abilities (Rabin et al., 2011, Yucel et al., 2012), and a less severe pattern of brain dysmorphology (Kumra et al., 2012) within the HASC compared to non-using SZ patients. In our previous cross-sectional data, we observed that early-onset schizophrenia (onset by age 18) (EOS) + CUD was associated with a larger brain volume in the right superior frontal cortex compared to non-using EOS patients. Previous longitudinal studies have found that there is an exaggerated pattern of cortical thinning in the HASC in adolescents with treatment-refractory childhood-onset schizophrenia (onset by age 12) (Sporn et al., 2003, Thompson et al., 2001), and in less severely ill adolescents with EOS (Arango et al., 2012), relative to HC. There has been one cross-sectional study suggesting that the presence of CUD is associated with more exaggerated cortical gray matter deficits in adolescents with EOS (James et al., 2011). To our knowledge, there have been no longitudinal studies conducted in adolescents with CUD, with or without comorbid EOS. Characterizing the effects of CUD on adolescent brain development in EOS is important: (1) to identify potential differences in pathophysiology between EOS and EOS + CUD; and (2) to determine whether the effects of CUD on brain morphology are dependent on diagnostic grouping.
To date, there have been no longitudinal studies that have examined the impact of CUD on adolescent cortical GM development. The present study aimed to examine the impact of CUD on cortical development in HASC over an 18-month period in both nonpsychotic and psychotic adolescents. On the basis of our cross-sectional data (Kumra et al., 2012) and the existing literature, we hypothesized that: (1) The magnitude of cortical thinning would be altered for CUD (+) compared to CUD (−) across HASC regions, based on preclinical data suggesting that adolescent exposure to cannabis could disrupt cortical GM development (Bossong and Niesink, 2010), and prior morphometric data demonstrating differences in cortical thickness and brain volumes associated with CUD in both typical (Lopez-Larson et al., 2011) and atypical development (Jarvis et al., 2008, Kumra et al., 2012); and (2) The magnitude of these alterations would be related to the amount of cannabis consumed. As an exploratory aim, we examined the relationship between neurocognitive performance and change in cortical thickness within the HASC. Here we hypothesized that greater loss of cortical thickness in the superior frontal gyrus (SFG) in HC would be related to improvement on a test of planning and problem solving (the Delis–Kaplan Executive Function System (D-KEFS) Tower Test (Delis et al., 2001)), as the slow development of planning performance during adolescence (Luciana et al., 2009) may be related to GM structural changes in the SFG (Burgaleta et al., 2014).
Section snippets
Study participants
The methods of this study have been described in detail elsewhere (Kumra et al., 2012). In brief, a sample of children and adolescents with EOS (n = 55), CUD (n = 31), and HC (n = 55) between the ages of 10 to 23 years were recruited from the clinical programs at the University of Minnesota Medical Center in Minneapolis under an approved Institutional Review Board protocol. Baseline differences in volume measurements have been previously reported (Kumra et al., 2012). A subgroup (28 EOS, 17 CUD, 34
Demographics and substance use
The study included four groups of participants: HC without a history of substance use disorders (n = 34), treatment-seeking adolescents with CUD (n = 17), EOS without CUD (n = 17), and EOS + CUD (n = 11) (Table 1). No demographic differences were found between participants with EOS who had both baseline and 18-month follow-up MRI assessments (28 EOS) and those who did not (27 EOS) (Supplementary Table 1). Among participants who completed both scans, a comparison of CUD (+) (n = 28) and CUD (−) (n = 51)
Discussion
To our knowledge, this is the first longitudinal study to evaluate whether CUD has an effect on adolescent brain development. The study was ambitious in its scope and it proved challenging to convince adolescents with CUD to volunteer to participate in the longitudinal study. Although the sample size was small, which limited study power, we were able to replicate prior findings of greater cortical thinning across HASC regions in HC (Gogtay et al., 2004) and in EOS (Arango et al., 2012, Thompson
Role of the funding source
This study was funded by the National Institute of Mental Health Grant MH073150-05 (Cannabis and Schizophrenia; to S.K.). The funding source played no role in the study design, in the collection, analysis, or interpretation of the data, in the writing of this manuscript, or in the decision to submit it for publication.
Contributors
Dr. Kumra designed the study and wrote the protocol. Dr. Kumra and Ms. Epstein managed the literature searches, conducted statistical analyses, and wrote the manuscript together. Both authors contributed to and have approved the final manuscript.
Conflict of interest
Dr. Kumra has received research support from the National Alliance for Research on Schizophrenia and Depression and Otsuka Pharmaceutical Co., Ltd., and plans to receive future research support from SyneuRx International (Taiwan) Corp. Ms. Epstein has no financial disclosures or potential conflicts of interest to report.
Acknowledgments
We thank Susanne Lee, Ph.D., who served as our statistical expert, and Lois Laitinen, M.M., M.B.A., for her support.
References (60)
- et al.
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs
Biol. Psychiatry
(2010) - et al.
Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders
Pharmacol. Res.
(2007) - et al.
Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia
Prog. Neurobiol.
(2010) - et al.
Cognitive ability changes and dynamics of cortical thickness development in healthy children and adolescents
Neuroimage
(2014) - et al.
Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls
Neuroimage
(2012) - et al.
Adolescent cortical development: a critical period of vulnerability for addiction
Pharmacol. Biochem. Behav.
(2007) - et al.
Cannabis use disorders in schizophrenia: effects on cognition and symptoms
Schizophr. Res.
(2010) - et al.
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Neuroimage
(2006) - et al.
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain
Neuron
(2002) - et al.
Wiring and firing neuronal networks: endocannabinoids take center stage
Curr. Opin. Neurobiol.
(2008)
Morphometric study of human cerebral cortex development
Neuropsychologia.
Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)
Schizophr. Res.
The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review
Psychiatry Res.
Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders
J. Am. Acad. Child Adolesc. Psychiatry
The Brief Psychiatric Rating Scale for Children (BPRS-C): validity and reliability of an anchored version
J. Am. Acad. Child Adolesc. Psychiatry
Cannabinoid receptor blockade reveals parallel plasticity mechanisms in different layers of mouse visual cortex
Neuron.
Altered prefrontal and insular cortical thickness in adolescent marijuana users
Behav. Brain Res.
Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use
Brain Res.
Abnormal cerebellar morphometry in abstinent adolescent marijuana users
Psychiatry Res.
Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry
Neurotoxicol. Teratol.
Growth of white matter in the adolescent brain: myelin or axon?
Brain Cogn.
Early-onset cannabis use and cognitive deficits: what is the nature of the association?
Drug Alcohol Depend.
The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis
Schizophr. Res.
Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia
Eur. Neuropsychopharmacol.
Cannabis use and cognitive functioning in first-episode schizophrenia patients
Schizophr. Res.
Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach
Trends Neurosci.
Negative symptoms in schizophrenia. Definition and reliability
Arch. Gen. Psychiatry
Progressive brain changes in children and adolescents with first-episode psychosis
Arch. Gen. Psychiatry.
Long-term effects of cannabis on brain structure
Neuropsychopharmacology.
Morphometric assessment of the heteromodal association cortex in schizophrenia
Am. J. Psychiatry
Cited by (35)
Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development
2023, Psychiatric Clinics of North AmericaImpact of Adolescent Cannabis Use on Neurocognitive and Brain Development
2023, Child and Adolescent Psychiatric Clinics of North AmericaCitation Excerpt :A 3-year longitudinal study of adolescent cannabis and alcohol users found reduced thinning of the cortex (ie, thicker cortex) in prefrontal, parietal, temporal, and occipital cortex, with greater cumulative marijuana use associated with increased thickness in temporal cortex at the follow-up visit.101 Similarly, a small study of adolescent cannabis users followed over 18 months showed reduced levels of cortical thinning (ie, thicker cortex) in prefrontal, temporal, and parietal regions.112 In contrast to findings of diminished cortical thickness from smaller studies, a recent, large-scale longitudinal study of 799 adolescents from the community-based IMAGEN cohort found that lifetime cannabis use was associated with accelerated cortical thinning from ages 14 to 19 in bilateral prefrontal cortex.113
Legalization of cannabis use in Canada: Impacts on the cannabis use profiles of youth seeking services for substance use
2021, Journal of Substance Abuse TreatmentAnterior cingulate volume reductions in abstinent adolescent and young adult cannabis users: Association with affective processing deficits
2019, Psychiatry Research - Neuroimaging